Arterra Bioscience
ARBS.MI · MIL
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €3 | €2 | €3 | €1 |
| % Growth | 33.8% | -24.9% | 136% | – |
| Cost of Goods Sold | €2 | €2 | €1 | €0 |
| Gross Profit | €0 | €0 | €1 | €1 |
| % Margin | 18.6% | 20.3% | 55% | 57.1% |
| R&D Expenses | €0 | €2 | €0 | €2 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €1 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | -€2 | €0 | -€2 |
| Operating Expenses | €0 | €0 | €1 | €0 |
| Operating Income | €0 | €0 | €1 | -€0 |
| % Margin | 15.8% | 15.5% | 20% | -9.4% |
| Other Income/Exp. Net | €1 | €1 | €0 | €1 |
| Pre-Tax Income | €1 | €1 | €1 | €1 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | €1 | €1 | €1 | €1 |
| % Margin | 42.2% | 42.6% | 20.2% | 76.3% |
| EPS | 0.16 | 0.12 | 0.078 | 0.12 |
| % Growth | 33.3% | 54.4% | -35.2% | – |
| EPS Diluted | 0.16 | 0.12 | 0.078 | 0.12 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | -€0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €1 | €1 | €1 | €1 |
| % Margin | 47.7% | 65% | 23.2% | 112.6% |